Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 3 5Phase 1/2 5Phase 2/3 3Phase 1 1

Status

Not yet recruiting 2Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 93Stomach Neoplasms 56Rectal Neoplasms 51Colonic Neoplasms 47Pancreatic Neoplasms 20Neoplasms 14Carcinoma, Hepatocellular 14Neoplasm Metastasis 13Adenocarcinoma 10Parkinson Disease 4, Autosomal Dominant Lewy Body 9Lymphoma, Large B-Cell, Diffuse 9Cholangiocarcinoma 8Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 5Biliary Tract Neoplasms 5Neurotoxicity Syndromes 4Esophageal Squamous Cell Carcinoma 4Lymphoma, Extranodal NK-T-Cell 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Peritoneal Neoplasms 2Lymphoma 2Liver Neoplasms 2Hepatoblastoma 2Gastrointestinal Diseases 2Colorectal Adenocarcinoma 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Spinocerebellar Degenerations 1

Interventions

Gemcitabine 13Cisplatin 11durvalumab 7Oxaliplatin 5Capecitabine 5Fluorouracil 4S 1 (combination) 3Leucovorin 3Irinotecan 3zanidatamab 2gemcitabine-oxaliplatin regimen 2Trastuzumab 2trastuzumab deruxtecan 1pembrolizumab 1niraparib 1neratinib 1ivosidenib 1futibatinib 1envafolimab 1encorafenib 1binimetinib 1becatecarin 1Tegafur 1Pancreaticojejunostomy 1NUC-1031 1Folfox protocol 1Drug Therapy 1Chemotherapy, Adjuvant 1Carboplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Biliary Tract Neoplasms × Oxaliplatin × Clear all
NCT07606599 2026-05-26

A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
398 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT07582315 2026-05-22

A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01)

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
538 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT07265674 2026-05-14

Beacon-BTC

J-Pharma Co., Ltd.

Phase 3 Recruiting
480 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT03478488 2025-05-29

KN035-BTC

3D Medicines

Phase 3 Active not recruiting
480 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT01926236 2020-01-28

ABC06

The Christie NHS Foundation Trust

Phase 3 Completed
162 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡